Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure
- PMID: 7362716
- PMCID: PMC482266
- DOI: 10.1136/hrt.43.2.220
Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure
Abstract
To examine possible augmentation of the effects of isosorbide dinitrate by salbutamol, haemodynamic measurements were made in 10 patients with severe chronic congestive cardiac failure who received isosorbide dinitrate 2.5 to 25 mg sublingually and salbutamol 4 to 12 mg orally, alone and in combination. Isosorbide dinitrate reduced mean left ventricular filling pressure from 29 to 18 mmHg and increased mean cardiac index from 1.7 to 2.0 1/min per m2, with no significant change in mean heart rate. Systemic arterial mean pressure fell from 85 to 72 mmHg. Salbutamol increased cardiac index from 1.8 to 2.2 1/min per m2. There was no significant change in left ventricular filling pressure, heart rate, or systemic arterial pressure. Compared with control, combined isosorbide dinitrate and salbutamol reduced left ventricular filling pressure from 27 to 19 mmHg and increased cardiac index from 1.8 to 2.7 1/min per m2, with no significant change in heart rate. Systemic arterial pressure fell from 82 to 75 mmHg. The reduction in left ventricular filling pressure by combined treatment was similar to that produced by isosorbide dinitrate alone, but the increase in cardiac index was significantly greater than that produced either by isosorbide dinitrate alone or salbutamol alone. Combined sublingual isosorbide dinitrate and oral salbutamol have an additive effect in improving left ventricular performance in patients with severe chronic congestive cardiac failure.
Similar articles
-
Improvement in exercise haemodynamics by isosorbide dinitrate in patients with severe congestive cardiac failure secondary to ischaemic heart disease.Br Heart J. 1978 Aug;40(8):832-7. doi: 10.1136/hrt.40.8.832. Br Heart J. 1978. PMID: 687484 Free PMC article.
-
Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.Am J Cardiol. 1976 Feb;37(2):263-8. doi: 10.1016/0002-9149(76)90322-2. Am J Cardiol. 1976. PMID: 1108634 Review.
-
Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.Am J Cardiol. 1977 Jan;39(1):84-90. doi: 10.1016/s0002-9149(77)80016-7. Am J Cardiol. 1977. PMID: 318795 Clinical Trial.
-
Comparison of acute haemodynamic effects of nifedipine and isosorbide dinitrate in patients with heart failure following acute myocardial infarction.Int J Cardiol. 1981;1(2):151-63. doi: 10.1016/0167-5273(81)90028-0. Int J Cardiol. 1981. PMID: 7338418
-
Role of isosorbide dinitrate in management of chronic congestive heart failure.Am Heart J. 1985 Jul;110(1 Pt 2):264-8. doi: 10.1016/0002-8703(85)90498-3. Am Heart J. 1985. PMID: 3893081 Review.
Cited by
-
Combination of positive inotropic and vasodilating substances in congestive heart failure.Cardiovasc Drugs Ther. 1988 May;2(1):83-91. doi: 10.1007/BF00054257. Cardiovasc Drugs Ther. 1988. PMID: 3154699 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical